Short answer · Medically reviewed summary · Last updated: 2026-04-07
Progressive multifocal leukoencephalopathy (PML) is a rare and serious viral disease of the brain, most commonly referred to by its abbreviation, PML. While it is occasionally historicaly referred to as "multifocal leukoencephalopathy," the term Progressive multifocal leukoencephalopathy remains the universally accepted clinical and academic designation in modern medical literature. What are the synonyms and historical names for Progressive multifocal leukoencephalopathy? In clinical practice and medical documentation, Progressive multifocal leukoencephalopathy is almost exclusively referred to by its full name or the acronym PML.
Progressive multifocal leukoencephalopathy synonyms
Other names for Progressive multifocal leukoencephalopathy: synonyms, acronyms and related terms used by doctors and patients.
Progressive multifocal leukoencephalopathy (PML) is a rare and serious viral disease of the brain, most commonly referred to by its abbreviation, PML. While it is occasionally historicaly referred to as "multifocal leukoencephalopathy," the term Progressive multifocal leukoencephalopathy remains the universally accepted clinical and academic designation in modern medical literature.
What are the synonyms and historical names for Progressive multifocal leukoencephalopathy?
In clinical practice and medical documentation, Progressive multifocal leukoencephalopathy is almost exclusively referred to by its full name or the acronym PML. Historically, the condition was sometimes described broadly as "multifocal leukoencephalopathy," though this lacks the descriptive accuracy regarding the disease's progressive nature. Because Progressive multifocal leukoencephalopathy is a specific demyelinating disease caused by the JC virus, it is rarely confused with other conditions, meaning there are very few alternative names in circulation. You will not find significant variations in nomenclature across different countries, as the medical community maintains a unified standard to ensure clarity in diagnostic reporting.
How is Progressive multifocal leukoencephalopathy classified in medical systems?
Official medical classification systems provide standardized codes to ensure consistent documentation for Progressive multifocal leukoencephalopathy across global healthcare systems. These classifications are essential for insurance, research, and epidemiological tracking. Key identifiers include:
- ICD-10: A81.2 (Progressive multifocal leukoencephalopathy)
- ICD-11: 1C82.0 (Progressive multifocal leukoencephalopathy)
- Orphanet: ORPHA:511 (Progressive multifocal leukoencephalopathy)
- OMIM: While not a single-gene disorder, it is referenced in the context of JC virus-related pathology under various clinical profiles.
Why does this condition have a specific, descriptive name?
The name Progressive multifocal leukoencephalopathy is highly descriptive, which is common for neurological conditions identified before the discovery of the specific causative agent. The name breaks down as follows:
- Progressive: Reflects the worsening nature of the neurological deficits over time.
- Multifocal: Indicates that the damage occurs in multiple, scattered locations throughout the white matter of the brain.
- Leukoencephalopathy: "Leuko" refers to white matter, "encephalo" to the brain, and "pathy" to disease.
Medical professionals prefer this name because it immediately conveys the pathology: a white matter disease that spreads across various brain regions in a progressive fashion. Our DiseaseMaps.org community currently includes 16 people with Progressive multifocal leukoencephalopathy who utilize this standard terminology to share their experiences and navigate care.
Is there confusion between Progressive multifocal leukoencephalopathy and other conditions?
While the name Progressive multifocal leukoencephalopathy is distinct, patients sometimes confuse it with other white matter diseases or leukodystrophies. However, unlike genetic leukodystrophies, this is a secondary condition caused by the reactivation of the JC virus in immunocompromised individuals. Because the name is so specific, it is rare to encounter "synonyms" in the traditional sense; rather, you may see it referred to in the context of its association with specific immunosuppressive medications or underlying conditions like HIV/AIDS or hematological malignancies.
Next steps
- Consult a neurologist or neuro-infectious disease specialist if you suspect symptoms related to Progressive multifocal leukoencephalopathy.
- Request a copy of your MRI and cerebrospinal fluid (CSF) analysis, ensuring the diagnosis is documented using the ICD-10 code A81.2.
- Connect with the 16 members of the DiseaseMaps.org community to share experiences and find peer support.
- Review the latest clinical trial data on NIH GARD to understand emerging therapies for JC virus-related brain conditions.
Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.
References
- Orphanet: Rare Disease Database (ORPHA:511)
- NIH Genetic and Rare Diseases Information Center (GARD)
- World Health Organization: ICD-11 Browser
- PubMed/NCBI: Clinical review of JC virus and PML
